Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

Pulsatile Compression of StentGraft by Re-pressurizing Aneurysmal Sac With Type III Endoleak After Endovascular Aneurysm Repair: A Case Report

Oh PC, Jang AY, Kang WC

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Echocardiographic Screening Methods for Pulmonary Hypertension: A Practical Review

Jang AY, Shin MS

Pulmonary hypertension (PH) is a debilitating condition defined as mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg. The importance of impaired right ventricular (RV) hemodynamics is increasingly being recognized in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension

Yeo J, Shin N, Ahn KJ, Seo M, Jang AY, Kim M, Chung WJ

Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary Hypertension in Heart Failure

Jang AY, Park SJ, Chung WJ

Pulmonary hypertension (PH) is traditionally defined as a mean pulmonary arterial pressure (mPAP) ≥25 mmHg. Although various factors cause PH, the most common etiology is PH due to left heart...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current status of pulmonary arterial hypertension in Korea

Jang AY, Chung WJ

Pulmonary arterial hypertension (PAH) is characterized by remodeling of the distal pulmonary arteries resulting in high pulmonary vascular resistance and, eventually, right ventricular heart failure. Although current advances in PAH...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Stem Cell and Exosome Therapy in Pulmonary Hypertension

Oh S, Jung JH, Ahn KJ, Jang AY, Byun K, Yang PC, Chung WJ

Pulmonary hypertension is a rare and progressive illness with a devastating prognosis. Promising research efforts have advanced the understanding and recognition of the pathobiology of pulmonary hypertension. Despite remarkable achievements...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Smoking and Periodontal Disease in Korean Adults: The Fifth Korea National Health and Nutrition Examination Survey (2010 and 2012)

Jang AY, Lee JK, Shin JY, Lee HY

BACKGROUND: This study aimed to evaluate an association between smoking, smoking cessation, and periodontal disease in Korean adults. METHODS: The data were collected from 8,336 participants, aged between 20 and 64...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Binding of the Streptococcus gordonii Surface Glycoprotein Hsa to alpha(2-3) Linked Sialic Acid Residues on Fibronectin

Jang AY, Lin S, Lim S, Kim DH, Seo HS

The binding of microorganisms to platelets is a critical step in the development of infective endocarditis. In Streptococcus gordonii, this binding is mediated in part by serine-rich repeat proteins, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Valsartan Dosage on Ventriculo-Vascular Coupling Index Dose-Dependency in Heart Failure Patients

Ahn KJ, Yu J, Jang AY, Kim DH, Kwan J, Chung WJ

Purpose: Heart failure (HF) poses significant morbidity and mortality. Recently, the ventriculo-vascular coupling index (VVI) was introduced as an independent prognostic factor reflective of the overall cardiovascular performance index in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiac Structural or Functional Changes Associated with CHAâ‚‚DSâ‚‚-VASc Scores in Nonvalvular Atrial Fibrillation: A Cross-Sectional Study Using Echocardiography

Jang AY, Yu J, Park YM, Shin MS, Chung WJ, Moon J

BACKGROUND: CHA2DS2-VASc is the most widely accepted scoring system for atrial fibrillation (AF) to assess stroke risk, although little has been revealed regarding the accompanying cardiac functional/structural changes. This echocardiography...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002–2018

Jang AY, Lee HH, Lee H, Kim HC, Chung WJ

Background and Objectives: Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Recent advances in PAH-specific drugs have improved its outcomes, although the healthcare burden of novel therapeutics may...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation

Ahn KJ, Jang AY, Park SJ, Chung WJ

Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Feasibility and Applicability of Wireless Handheld Ultrasound Measurement of Carotid Intima-Media Thickness in Patients with Cardiac Symptoms

Jang AY, Ryu J, Oh PC, Moon J, Chung WJ

PURPOSE: Routine screening for carotid intima-media thickness (CIMT) and cardiovascular (CV) disease in asymptomatic patients has been criticized for the high costs and large number of patients required for detecting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort

Jang AY, Kim S, Park SJ, Choi H, Oh PC, Oh S, Kim KH, Kim KH, Byun K, Chung WJ, for the PHOENIKS Investigators

BACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive, chronic disease without curative treatment. Large registry data of these patient populations have been published, although, phenotypic variants within each subtype of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr